RAC 2.37% $1.65 race oncology ltd

For a drug like Bisantrene isn’t the clinical trial result the...

  1. 7,173 Posts.
    lightbulb Created with Sketch. 1835
    For a drug like Bisantrene isn’t the clinical trial result the key risk or uncertainty? Once you prove that we would be expecting the BP’s lining up to court us. Race has no plan to commercialise the drug themselves based on what they have told us to date. It will be up to whichever partner/ acquirer to commercialise it, and let’s hope they do so for the sake of humanity.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.